BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28189)

  • 1. Considerations on physiopathological approaches to the treatment of hypertension.
    Zanchetti A; Leonetti G; Morganti A; Terzoli L
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():1-9. PubMed ID: 28189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physiopathological and clinical approaches to the treatment of hypertension (author's transl)].
    Zanchetti A
    Ann Cardiol Angeiol (Paris); 1979; 28(1):1-4. PubMed ID: 35085
    [No Abstract]   [Full Text] [Related]  

  • 3. [Role of renin profile and age in the choice of the therapeutic approach of arterial hypertension (author's transl)].
    Glorioso N; Madeddu P; Dessì Fulgheri P; Sanna G; Fiori C; Dettori S; Cocco F; Rappelli A
    G Ital Cardiol; 1981; 11(12):2117-25. PubMed ID: 6125451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination of betablocking-vasodilator and diuretic agents in the treatment of arterial hypertension. Changes in Hemodynamics and plasma-renin levels].
    Fernández-Andrade C; Herrera Carranza M; Villalobos Galán E; Mateos Aguilar J; Quereda C; Navarro R; Martinez Martin A; Mendoza Llera M
    Rev Clin Esp; 1978 Mar; 148(5):491-6. PubMed ID: 27844
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact on serum lipids of combinations of diuretics and beta-blockers and of beta-blockers alone.
    Helgeland A
    J Cardiovasc Pharmacol; 1984; 6 Suppl 3():S474-6. PubMed ID: 6208414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-Adrenoceptor blockers in the treatment of hypertension.
    Falase AO; Salako LA
    Afr J Med Med Sci; 1979; 8(1-2):13-8. PubMed ID: 45432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypertension treatment in the elderly].
    Korn A
    Wien Med Wochenschr; 1981 Feb; 131(4):91-3. PubMed ID: 6112819
    [No Abstract]   [Full Text] [Related]  

  • 9. [Relation between the hypotensive and renin-stimulating effect of diuretic therapy in hypertensive patients].
    Bianchini C; Sala C; Terzoli L; Sernesi L; Leonetti G; Zanchetti A
    Boll Soc Ital Cardiol; 1978; 23(10):1739-47. PubMed ID: 400389
    [No Abstract]   [Full Text] [Related]  

  • 10. [Beta-blocking agents alone or combined with diuretics or alpha-adrenolytics in the treatment of essential arterial hypertension].
    Minutillo S; Lupinc V; D'Agnolo B
    Minerva Med; 1979 Dec; 70(57):3919-24. PubMed ID: 43488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium antagonists, firstline partners for betablockers in hypertension.
    Bühler FR
    Z Kardiol; 1984; 73 Suppl 2():95-9. PubMed ID: 6152093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha 2-adrenoceptor agonists in the treatment of hypertension.
    Kaplan NM
    J Cardiovasc Pharmacol; 1985; 7 Suppl 8():S64-6. PubMed ID: 2417050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of renin after betablocking diuretic and vasodilator treatment in essential hypertension (author's transl)].
    Lombardo M; Fusco M; Valente D
    G Ital Cardiol; 1979; 9(12):1363-70. PubMed ID: 45015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The renin-angiotensin-aldosterone system in hypertensive subjects. III- The use of beta-blockers in reno-vascular hypertension (author's transl)].
    Lardoux H; Vial FS; Ménard J; Corvol P; Milliez P
    Nouv Presse Med; 1977 Sep; 6(30):2659-63. PubMed ID: 20602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic and hormonologic basis of the treatment of arterial hypertension].
    Guédon J; Lucsko M; Chaignon M
    Arch Mal Coeur Vaiss; 1974 Oct; 67(10):1145-55. PubMed ID: 4156640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of action of beta-adrenergic blocking drugs in hypertension.
    Prichard BN; Owens CW
    Clin Physiol Biochem; 1990; 8 Suppl 2():1-10. PubMed ID: 1982756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in the treatment of essential hypertension.
    Sharma PL; Pandhi P
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S54-61. PubMed ID: 2432023
    [No Abstract]   [Full Text] [Related]  

  • 19. The place of the calcium antagonist verapamil in antihypertensive therapy.
    Bühler FR; Hulthén UL; Kiowski W; Müller FB; Bolli P
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S350-7. PubMed ID: 6184567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta blockers in hypertension: a review.
    Kelly KL
    Am J Hosp Pharm; 1976 Dec; 33(12):1284-90. PubMed ID: 11687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.